Company Information
AIM rule 26
The following information is provided for AIM rule 26 compliance.
Company Secretary: Salim Hamir
Registered address and Head Office:
EKF Diagnostics Holdings plc
Avon House, 19 Stanwell Road, Penarth, Cardiff CF64 2EZ
Country of Incorporation: United Kingdom
Main countries of operation: United Kingdom, Germany, Poland, Russia, USA and China
Company registration number: 04347937
TIDM: EKF
VAT number: 805940921
Date shares admitted for trading: 7th July 2010
Website last updated: 14th December 2018
Share information
Exchanges where quoted and traded: EKF Diagnostics securities are not traded on any exchanges or trading platforms other than AIM.
Number of AIM securities in issue: 454,093,227 shares are issued, called up and fully paid.
Percentage of securities not in public hands: As at 14/12/2018 the percentage of AIM securities not in public hands was 57.99%.
Restrictions on the transfer of securities: There is no restriction on the transfer of EKF Diagnostics Holdings plc securities.
Significant shareholders
|
Significant shareholders |
No. of ordinary shares | % held |
|
Harwood Capital |
135,963,593 |
29.94% |
|
Lombard Odier Investment Managers |
43,920,473 |
9.67% |
|
Schroders Investment Management |
20,025,000 |
4.41% |
|
Cannaccord Genuity Wealth Management |
18,200,000 |
4.01% |
|
Mr William Pippin |
16,189,675 |
3.57% |
|
Octopus Investments |
14,504,500 |
3.19% |
Directors' shareholdings
| Shareholder | No. of ordinary shares | % held |
|
Christopher Mills |
135,963,593 |
29.94% |
|
Adam Reynolds |
3,318,613 |
0.73% |
|
Julian Baines |
1,855,288 |
0.41% |
|
Richard Evans |
178,842 |
0.04% |
*Christopher Mills is partner and Chief Investment Officer of Harwood Capital LLP. Harwood Capital LLP is Investment Manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Christopher’s shareholding is made up of 98,000,000 ordinary shares held by North Atlantic Smaller Companies Investment Trust PLC and 37,963,591 ordinary shares are held by Oryx International Growth Fund Limited.
View the Annual Report 2017 for EKF Diagnostics Holdings plc
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.